Literature DB >> 12030996

Randomized controlled trial of oral versus intravenous fluid supplementation on serum bilirubin level during phototherapy of term infants with severe hyperbilirubinaemia.

N-Y Boo1, H-T Lee.   

Abstract

OBJECTIVE: To compare the rates of decrease in serum bilirubin levels in severely jaundiced healthy term infants given oral or intravenous fluid supplementation during phototherapy.
METHODS: A randomized controlled study was carried out in the neonatal intensive care unit (NICU) of Hospital Universiti Kebangsaan Malaysia over a 12-month period. Fifty-four healthy term infants with severe hyperbilirubinemia were randomized to receive either solely enteral feeds (n = 27) or both enteral and intravenous (n = 27) fluid during phototherapy.
RESULTS: There were no significant differences in the mean birthweight, mean gestational age, ethnic distribution, gender distribution, modes of delivery and types of feeding between the two groups. Similarly, there was no significant difference in the mean indirect serum bilirubin (iSB) level at the time of admission to the NICU between the enteral (359 +/- 69 micromol/L [mean +/- SD]) and intravenous group (372 +/- 59 micromol/L; P = 0.4). The mean rates of decrease in iSB during the first 4 h of phototherapy were also not significantly different between the enteral group (10.4 +/- 4.9 micromol/L per h) and intravenous group (11.2 +/- 7.4 micromol/L per h; P = 0.6). There was no significant difference in the proportion of infants requiring exchange transfusion (P = 0.3) nor in the median duration of hospitalization (P = 0.7) between the two groups. No infant developed vomiting or abdominal distension during the study period.
CONCLUSION: Severely jaundiced healthy term infants had similar rates of decrease in iSB levels during the first 4 h of intensive phototherapy, irrespective of whether they received oral or intravenous fluid supplementation. However, using the oral route avoided the need for intravenous cannulae and their attendant complications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030996     DOI: 10.1046/j.1440-1754.2002.00746.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  4 in total

1.  Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: a nested case-control study.

Authors:  Michael W Kuzniewicz; Gabriel J Escobar; Soora Wi; Petra Liljestrand; Charles McCulloch; Thomas B Newman
Journal:  J Pediatr       Date:  2008-03-21       Impact factor: 4.406

2.  Fluid supplementation in hyperbilirubinemia.

Authors:  Shiv Sajan Saini; Praveen Kumar; Karthik Balasubramanium; Shailender Mehta
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

3.  Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - Summary.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-05       Impact factor: 2.253

Review 4.  Fluid supplementation for neonatal unconjugated hyperbilirubinaemia.

Authors:  Nai Ming Lai; Azanna Ahmad Kamar; Yao Mun Choo; Juin Yee Kong; Chin Fang Ngim
Journal:  Cochrane Database Syst Rev       Date:  2017-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.